Upload Avatar (500 x 500)
Shaobo Ke
Medical School
Wuhan University
Hubei
Language: Chinese, English
Targeted Therapy
Immunotherapy
Digestive System Tumors
Precision Medicine
Clinical Trials
Radiation Oncology
Molecular Biology
Cancer Research
Tumor Microenvironment
Immune Regulation
Areas of Focus
- Tumor targeted therapy
- Tumor immune microenvironment regulation
Work Experience
- 2007/07-2012/08, Renhe Hospital affiliated to Three Gorges University, Attending Physician
- 2015/07-2019/10, Cancer Center, Renmin Hospital of Wuhan University, Attending Physician
- 2019/11-present, Cancer Center, Renmin Hospital of Wuhan University, Deputy Chief Physician and Deputy Director
Academic Background & Achievements
- 2000/09–2005/07, Bachelor of Clinical Medicine, Hubei University of Science and Technology
- 2005/09–2007/07, Master of Surgery, First Clinical College of Wuhan University
- 2012/09–2015/07, PhD in Oncology, Second Clinical College of Wuhan University
- Led and participated in 5 national and provincial projects
Publications
- Efficacy of endoscopic therapy for T1b esophageal cancer and construction of prognosis prediction model: A retrospective cohort study, Shaobo Ke et al., 2023
- USP14 promotes colorectal cancer progression by targeting JNK for stabilization, Shaobo Ke et al., 2023
- An exploratory clinical trial of apatinib combined with intensity modulated radiation therapy for patients with unresectable hepatocellular Carcinoma, Shaobo Ke et al., 2023
- Regional Lymph Node Metastasis and Axillary Surgery of Microinvasive Breast Cancer: A Population-Based Study, Shaobo Ke et al., 2022
- Evaluation of Concurrent Chemoradiotherapy in Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma, Shaobo Ke et al., 2022
- Knockdown of circRNA circ_0087378 represses the tumorigenesis and progression of esophageal squamous cell carcinoma through modulating the miR-140-3p/E2F3 axis, Shaobo Ke et al., 2020
- ALG3 Contributes to the Malignancy of Non-small Cell Lung Cancer and Is Negatively Regulated by MiR-98-5p, Shaobo Ke et al., 2020
- Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor(EGFR-TKI)Combined with Whole Brain Radiotherapy in EGFR Mutation-positive Lung Adenocarcinoma Patients with Brain Metastases, Shaobo Ke et al., 2018
- Downregulation of high mobility group box 1 modulates telomere homeostasis and increases the radiosensitivity of human breast cancer cells, Shaobo Ke et al., 2015
